New Jersey S 3151: Allows NJ gross income tax deduction for charitable contributions of food made from business inventory.

Bill Text

S3151 

SENATE, No. 3151 

STATE OF NEW JERSEY

222nd LEGISLATURE

� 

PRE-FILED FOR INTRODUCTION IN THE 2026 SESSION

Sponsored by:

Senator NICHOLAS P. SCUTARI

District 22 (Somerset and Union)

SYNOPSIS

���� Permits Governor to authorize interstate commercial 
cannabis activity in certain circumstances.

CURRENT VERSION OF TEXT 

���� Introduced Pending Technical Review by Legislative 
Counsel.

�� 

An Act concerning interstate transportation or distribution of 
medical or personal-use cannabis and amending and supplementing Title 24 of the 
Revised Statutes.

���� Be It 
Enacted by the Senate and General Assembly of 
the State of New Jersey:

���� 1.��� Section 14 of P.L.2009, 
c.207 (C.24:6I-12) is amended to read as follows:

���� 14. a. The commissioner, or 
after the effective dates of P.L.2019, c.153 (C.24:6I-5.1 et al.) and P.L.2021, 
c.16 (C.24:6I-31 et al.), the commission, shall report to the Governor, and to 
the Legislature pursuant to section 2 of P.L.1991, c.164 (C.52:14-19.1):

���� (1)�� no later than one year 
after the effective date of P.L.2009, c.307 (C.24:6I-1 et al.), on the actions 
taken to implement the provisions of P.L.2009, c.307 (C.24:6I-1 et al.); and

���� (2)�� annually thereafter on 
the number of applications for registration with the commission, the number of 
qualifying patients registered, the number of designated and institutional 
caregivers registered, the nature of the qualifying medical conditions of the 
patients, the number of registrations revoked, the number of medical cannabis 
cultivator, medical cannabis manufacturer, and medical cannabis dispensary 
permits issued and revoked, the number and type of integrated curricula 
approved, established, and maintained in connection with an IC permit, the 
number of testing laboratories licensed, the number of clinical registrant 
permits issued and the nature of the clinical research conducted by each 
clinical registrant, any incidents of diversion of medical cannabis, 
information concerning racial, ethnic, disabled veteran, and gender diversity 
in the individuals issued and currently holding permits issued by the 
commission, the number of permit applications received from businesses owned by 
minorities, disabled veterans, and women and the number of such applications 
that were approved, the business development initiatives undertaken by the 
Office of Minority, Disabled Veterans, and Women Cannabis Business Development 
pursuant to section 32 of P.L.2019, c.153 (C.24:6I-25) and the outcomes or 
effects of those initiatives, statistics concerning arrests for drug offenses 
throughout the State and in areas where medical cannabis dispensaries are 
located, including information concerning racial disparities in arrest rates for 
drug offenses generally and cannabis offenses in particular, the number of 
motor vehicle stops by law enforcement involving violations of R.S.39:4-50, or 
section 5 of P.L.1990, c.103 (C.39:3-10.13) concerning operators of commercial 
motor vehicles, for driving under the influence of medical cannabis, or 
suspicion thereof, cataloged by the jurisdictions in which the stop occurred, 
and the race, ethnicity, gender, and age of the vehicle driver and any other 
vehicle occupants, the number of deliveries of medical cannabis performed and 
the percentage of total medical cannabis dispensations that were completed by 
delivery, [and] the number of 
health care practitioners authorizing patients for the medical use of cannabis, 
including the types of license or certification held by those practitioners, 
and a list of interstate cannabis agreements entered into pursuant to section 2 
of P.L.��� , c.���� (C.��� )(pending before the Legislature as this bill), 
including information regarding the terms and conditions of each agreement, the 
activities undertaken by State agencies to implement the agreement, and the 
effects of the agreement on this State�s cannabis industry; and

���� (3)�� beginning no later than 
one year after the effective date of P.L.2021, c.16 (C.24:6I-31 et al.), and 
annually thereafter in the same report concerning information on medical 
cannabis activities or a separate report, information on:

���� (a)�� the number of citations, 
arrests, or charges for manufacturing, distributing, or possessing or having 
under control with the intent to distribute marijuana or hashish in violation 
of paragraph (12) of subsection b. of N.J.S.2C:35-5, or for obtaining or possessing 
marijuana or hashish in violation of paragraph (3) of subsection a. of 
N.J.S.2C:35-10, cataloged by the jurisdictions in which the acts resulting in 
the citations, arrests, or charges occurred, and the race, ethnicity, gender, 
and age of the persons cited, arrested, or charged;

���� (b)�� the number of motor 
vehicle stops by law enforcement involving violations of R.S.39:4-50, or 
section 5 of P.L.1990, c.103 (C.39:3-10.13) concerning operators of commercial 
motor vehicles, for driving under